Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cardillo

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Minerva Anestesiologica|June 1, 2000
[Systemic and pulmonary vascular resistance in brain death]V Gravame, M Cardillo, G Paganoni, et al.
Molecular Cancer|March 11, 2014
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Thomas M Cardillo, Yang Wang, et al.
International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.
Blood|November 21, 2007
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of actionZhengxing Qu, David M Goldenberg, Thomas M Cardillo, et al.
Molecular Cancer Therapeutics|July 29, 2010
Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cellsChien-Hsing Chang, Pankaj Gupta, Rosana Michel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA inductionP K Reddy, D V Gold, T M Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2017
Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in <i>BRCA1/2</i>-wild-type Triple-Negative Breast CancerThomas M Cardillo, Robert M Sharkey, Diane L Rossi, et al.
Veterinary Parasitology|September 11, 2018
Corrigendum to "Larval development of Aelurostrongylus abstrusus in experimentally infected Rumina decollata snails" [Vet. Parasitol. 251 (2018) 50-55]Natalia M Cardillo, Mariano Ercole, Fernando Fariña, et al.
Blood|June 18, 2011
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancersEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Minerva Anestesiologica|June 1, 2000
[Systemic and pulmonary vascular resistance in brain death]V Gravame, M Cardillo, G Paganoni, et al.
Molecular Cancer|March 11, 2014
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Thomas M Cardillo, Yang Wang, et al.
International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.
Blood|November 21, 2007
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of actionZhengxing Qu, David M Goldenberg, Thomas M Cardillo, et al.
Molecular Cancer Therapeutics|July 29, 2010
Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cellsChien-Hsing Chang, Pankaj Gupta, Rosana Michel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA inductionP K Reddy, D V Gold, T M Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2017
Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in <i>BRCA1/2</i>-wild-type Triple-Negative Breast CancerThomas M Cardillo, Robert M Sharkey, Diane L Rossi, et al.
Veterinary Parasitology|September 11, 2018
Corrigendum to "Larval development of Aelurostrongylus abstrusus in experimentally infected Rumina decollata snails" [Vet. Parasitol. 251 (2018) 50-55]Natalia M Cardillo, Mariano Ercole, Fernando Fariña, et al.
Blood|June 18, 2011
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancersEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.
Pageof 14